The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
HealthDay on MSN6h
FDA Approves Omvoh for Moderately to Severely Active Crohn DiseaseThe U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...
Hosted on MSN15h
Omvoh Approved for Crohn's; Fitbit Predicts IBD Flares; H. Pylori and Gastric CancerThe FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback